Bionomics Ltd ADR Analysis
BNOXDelisted Stock | USD 4.88 0.07 1.41% |
Bionomics Ltd ADR is overvalued with Real Value of 3.81 and Hype Value of 3.51. The main objective of Bionomics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Bionomics Ltd ADR is worth, separate from its market price. There are two main types of Bionomics' stock analysis: fundamental analysis and technical analysis.
The Bionomics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Bionomics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Bionomics Stock trading window is adjusted to America/New York timezone.
Bionomics |
Bionomics Stock Analysis Notes
About 34.0% of the company shares are held by company insiders. The company recorded a loss per share of 14.32. Bionomics ADR had not issued any dividends in recent years. The entity had 1:12 split on the 24th of December 2024. Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on NASDAQ Exchange in the United States. For more info on Bionomics Ltd ADR please contact Spyridon MD at 61 8 8150 7400 or go to https://www.bionomics.com.au.Bionomics ADR Investment Alerts
Bionomics ADR is now traded under the symbol NEUP. Please update your portfolios or report it if you believe this is an error. Report It! | |
Bionomics ADR is not yet fully synchronised with the market data | |
Bionomics ADR is way too risky over 90 days horizon | |
Bionomics ADR appears to be risky and price may revert if volatility continues | |
Bionomics ADR has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 20 K. Net Loss for the year was (15.49 M) with loss before overhead, payroll, taxes, and interest of (18.96 M). | |
Bionomics Ltd ADR currently holds about 33.56 M in cash with (14.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.46. | |
Roughly 34.0% of the company shares are held by company insiders |
Bionomics Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.95 M.Bionomics ADR Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bionomics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bionomics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bionomics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Papapetropoulos Spyros over two months ago Disposition of tradable shares by Papapetropoulos Spyros of Bionomics subject to Rule 16b-3 | ||
Wilson David Ian over three months ago Disposition of 100000 shares by Wilson David Ian of Bionomics at 0.2866 subject to Rule 16b-3 | ||
Wilson David Ian over six months ago Disposition of tradable shares by Wilson David Ian of Bionomics subject to Rule 16b-3 | ||
Papapetropoulos Spyros over six months ago Disposition of 1691688 shares by Papapetropoulos Spyros of Bionomics at 0.0321 subject to Rule 16b-3 |
Bionomics Outstanding Bonds
Bionomics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bionomics ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bionomics bonds can be classified according to their maturity, which is the date when Bionomics Ltd ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
BIOGEN INC 405 Corp BondUS09062XAF06 | View | |
BIOGEN INC Corp BondUS09062XAG88 | View | |
BIOGEN INC Corp BondUS09062XAH61 | View | |
BIIB 325 15 FEB 51 Corp BondUS09062XAK90 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Bionomics Predictive Daily Indicators
Bionomics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bionomics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Bionomics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Bionomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bionomics shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Bionomics. By using and applying Bionomics Stock analysis, traders can create a robust methodology for identifying Bionomics entry and exit points for their positions.
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on NASDAQ Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Bionomics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Bionomics Stock
If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |